is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Nic Bowman is Senior Director, Head of the Devices Centre of Excellence (DCoE), Pfizer R&D UK Ltd, based in Cambridge UK. He has a BSc in Mechanical Engineering from Bath University, England (1984). Nic joined Pfizer in 2008. As Head of DCoE he has responsibility to deliver device solutions for a range of combination products, covering a wide variety of delivery routes. Nic is a Fellow of the Institution of Mechanical Engineers (FIMechE). He is recognised expert in the field of device design, a regular conference speaker, and is named in over 20 patents.
David Braun is Global Head of Connected Health & Medical Device Business Solution for Merck Healthcare. David is an executive leader that has 20 years of experience in research and development, operations, strategy and business management worldwide. David is a Board director of Cellect, a biotech startup active in the field of stem cells and medical devices.
Before joining Merck, David served as Head of Operations and Global R&D of the Technology Business unit at Newell Brands, a Fortune 500 company, where he led key growth initiatives and multimillion-dollar projects. Prior to that, he worked as Vice President of R&D and Operations at Biosafe SA a medical device company acquired by GE, developing and launching medical devices at the forefront of technologies. Previously, David also held various senior management and engineering roles in the aerospace and high-tech industry.
David holds a master’s degree in applied physics from the Louis Pasteur University and a Degree in Electro-Optical Engineering from the Jerusalem College of Technology. He has participated in Executive leadership and general management programs at the Harvard Business School and IMD.
For more than 20 years at SANOFI, David Dronneau, was involved in the IT department in the first electronic submissions of dossier (NDA) and on electronic clinical trials before turning towards setting implementation of innovation process. For 4 years, he joined Clinical Supplies department as responsible Technologies, Innovation, and Process Solutions with a main objective: To develop innovative packaging that meets patient needs in following mainly three directions: Ensuring patient safety, improve usage and how to help improve patient compliance while ensuring continuity of operation in terms of development of solution and processes and finally ensuring the dissemination of business excellence good practices (LEAN) in the unit.
Lionel Jeannin is an Arts & Métiers ParisTech Engineer with a Master degree in Business Administration from IAE Aix-en-Provence. He has more than 17 years’ experience in the Medical Device and Pharmaceutical industry. He held Project Manager and Development Team Manager positions in the Industrial Engineering, Medical Devices for eye surgery, Parenteral Nutrition and OTC/Rx Pharmaceutical domains. He had the Global responsibility of Packaging Development for OTC Brands like Voltaren, Nicotinell and Fenistil and is currently in charge of Device & Packaging Development projects for new oral medications at Novartis Pharma AG. He is also a member of Novartis Pharma Drug Delivery e-Device / Digital Development network.
Franck Lescure is Partner in charge of Life Sciences investments at Elaia Partners. Until 2018, Franck was Partner in charge of Life Sciences activities at Auriga Partners. Between 1990 and 1995, he has participated to the initial years of Genset, one of the first French biotech startups. Between 1997 and 2002, he joined the Air Liquide group in its healthcare subsidiary, followed by 2 years as member of the Venture Capital team of Crédit Lyonnais Private Equity. Franck Cumulates 28 years of experience in technology innovation, including 17 years in Capital Venture. He notably led investments in TxCell, Median or Erytech and he is currently on the board of directors of Amoeba, Enobraq, Fabentech, Flash Tx, Nosopharm, Pherecydes and Pylote.
Franck is an alumnus of the Ecole Normale Supérieure and of the Institut Pasteur. He holds a PhD in Microbiology and Virology and a MBA from the Collège des Ingénieurs.
Dr Joël Richard is currently Chief Development Officer at MedinCell (Montpellier, France). He has 30 years of experience in chemistry and biopharmaceutical R&D, including several global senior positions in various Biotech and Pharma companies, such as Ipsen (France), Merck Serono (Italy, Germany), Ethypharm (France), Mainelab (France).
Dr Richard has graduated from Ecole Normale Supérieure (Cachan, France). He has got a PhD in Materials Science from University of Paris, France, and the “Habilitation à Diriger les Recherches” degree in Chemistry from University of Bordeaux I. He has published 68 peer-reviewed scientific papers, 8 book chapters and 2 review editorials in various fields (colloids and interfaces, drug delivery systems, supercritical fluids, protein formulations, nanoparticles,…). He is the author of more than 140 international communications and 55 patent families.
Cyril Thouseau is Global Open Innovation lead on Allergy, Cough & Cold category within Sanofi’s R&D Consumer Healthcare Business Unit. He is managing the category's efforts to access technology assets or capabilities through partnership agreements with various type of companies (Start’up, Universities, MNE and SME..). This position is supporting growth through access to new capabilities, strategies products, technologies, and IP, as well as supporting transformational innovation activities of the innovation group.
Before joining the Sanofi Consumer Healthcare GBU, Cyril held several positions in quality and industrial development departments within Sanofi Pasteur organization. During 17 years, Cyril was involved in key strategic End to End medical device developments linked to new vaccines and the device suppliers mastering (supply, quality, development.). Within Sanofi Pasteur, Cyril worked closely with R&D, Strategy and marketing departments in order to build and evaluate the next generation of medical devices in the vaccine marketplace.
Cyril holds an Executive MBA – International Business Development from Normandy Business School and is a graduate of Louis Pasteur University of Strasbourg, where he earned a Master’s Degree – Quality & Organisation.
Yves Th. Tillet is a doctor in pharmacy, graduate of physiology and biochemistry, of the Business Administration Institute, and of Marketing and Strategy from the Centre for Higher Education. Yves Th. Tillet began his professional career in the field of hospital biology and clinical pharmacy. In 1994, Yves Th. Tillet created with and Marie D. White the Cabinet WHITE-TILLET providing expertise in quality, assessment, and regulation of health products. He has taught at several French universities and is author of numerous publications.